Related Experiment Video
Updated: Dec 28, 2025
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Strontium/Chitosan/Hydroxyapatite/Norcantharidin Composite That Inhibits Osteosarcoma and Promotes Osteogenesis In
Zhipeng Huang1, Haoyuan Sun1, Yang Lu1
1The First Affiliated Hospital of Harbin Medical University, No. 23 Post Street, Nangang District, Harbin, Heilongjiang, China.
Abstract:
Hydroxyapatite can deliver drugs, and its composite material is capable of repairing bone defects in tumors. This study was conducted to evaluate the effect of composite materials on tumor growth inhibition and bone growth induction. Composites containing drug delivery compounds were synthesized by coprecipitation and freeze-drying and then characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FTIR). In addition, the effect of hydroxyapatite nanoparticles (nano-SHAP) on proliferation of an osteosarcoma cell line (MG-63) and an osteoblast cell line (MC3T3-E1) was evaluated, and its mechanism was studied. The use of nano-SHAP alone did not affect the proliferation of normal cell lines. However, nanoparticles containing different amounts of norcantharidin in the composite materials and had different inhibitory effects on osteosarcoma and different effects on osteoblasts. And, with the increase of the content of norcantharidin, the antitumor performance of the composite has been enhanced. In summary, the nano-SHAP system developed in this study is a drug delivery material that can inhibit the growth of tumors and induce the proliferation of osteoblasts.
Insights
Hydroxyapatite nanoparticles deliver drugs to inhibit osteosarcoma growth and promote bone healing. This composite material shows enhanced anti-tumor effects with increased drug content.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Hydroxyapatite (HA) composites show potential for bone defect repair and drug delivery.
- Osteosarcoma treatment requires effective tumor inhibition and bone regeneration strategies.
Purpose of the Study:
- To synthesize and characterize hydroxyapatite nanoparticles (nano-SHAP) for drug delivery.
- To evaluate the efficacy of nano-SHAP composites in inhibiting osteosarcoma cell proliferation and inducing osteoblast proliferation.
Main Methods:
- Composites synthesized via coprecipitation and freeze-drying.
- Characterization using SEM, XRD, and FTIR.
- In vitro evaluation of nano-SHAP effects on MG-63 (osteosarcoma) and MC3T3-E1 (osteoblast) cell lines.
Main Results:
- Nano-SHAP alone did not affect normal cell proliferation.
- Composites with norcantharidin showed dose-dependent inhibition of osteosarcoma cells.
- Enhanced anti-tumor performance correlated with increased norcantharidin content.
- Differential effects observed on osteosarcoma versus osteoblast cell lines.
Conclusions:
- The developed nano-SHAP system functions as an effective drug delivery material.
- This system demonstrates potential for inhibiting tumor growth and inducing osteoblast proliferation.
- The composite material offers a dual approach for treating bone defects in tumors.
